Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis
- PMID: 39038245
- PMCID: PMC11268792
- DOI: 10.1200/PO.24.00358
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis
Abstract
Biomarker-driven trials are key for precision oncology but challenge design and analysis.
Comment on
-
Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions.JCO Precis Oncol. 2024 Jun;8:e2400116. doi: 10.1200/PO.24.00116. JCO Precis Oncol. 2024. PMID: 38848518 Review.
References
-
- Wang J, Yu B, Dou Y, et al. : Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions. JCO Precision Oncology: TBD - PubMed
-
- Wasserstein RL, Lazar NA: The ASA Statement on p-Values: Context, Process, and Purpose. The American Statistician, 70(2), 129–133, 2016. 10.1080/00031305.2016.1154108 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
